| Visualitzacions | |
|---|---|
| Safety and immunogenicity of a modified vaccinia ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1 | 16 |
| gener 2024 | febrer 2024 | abril 2024 | |
|---|---|---|---|
| Safety and immunogenicity of a modified vaccinia ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1 | 8 | 5 | 3 |
| Visualitzacions |
|---|
| Visualitzacions | |
|---|---|
| Estats Units | 10 |
| Xina | 3 |
| Vietnam | 3 |
| Visualitzacions | |
|---|---|
| Ashburn | 6 |
| Hanoi | 3 |
| Shanghai | 3 |
| Ann Arbor | 2 |
| Cambridge | 1 |
| Houston | 1 |